Sending the right signalsEurekAlert (press release)His work focuses on merging biomechanical systems and the microscale and nanoscale with engineering living cells and smart material systems, the latter of which involves synthetic biology. Over the yea… Continue reading
|
ctDNA as a Blood-based Biomarker for Immunotherapy Response
Technology Networks Immunotherapy is giving patients with metastasized NSCLC a second chance at finding the right treatment for them. In fact, with new immunomodulatory drugs like the PD-1 inhibitors pembrolizumab and nivolumab, we’ve seen patients exhibit durable … |
|
ctDNA as a Blood-based Biomarker for Immunotherapy Response
Technology Networks Immunotherapy is giving patients with metastasized NSCLC a second chance at finding the right treatment for them. In fact, with new immunomodulatory drugs like the PD-1 inhibitors pembrolizumab and nivolumab, we’ve seen patients exhibit durable … |
The Scientist |
Skin Graft-based Gene Therapy Treats Diabetes in Mice
The Scientist skin graft An immunofluorescence image of one of the engineered skin graftsXIAOYANG WU ET AL.In a proof of concept study, researchers have used a gene-edited skin graft to treat diabetes in mice, they reported yesterday (August 3) in Cell Stem Cell. Gene therapy via skin could treat many diseases, even obesityScience Daily CRISPR Gene Therapy via Skin Grafts Treats Obesity and Diabetes in MiceGenetic Engineering & Biotechnology News This new gene therapy via skin can help treat diabetes, obesityZee News ResearchGate (blog) –CNBC –New Atlas all 18 news articles » |
KL Daily |
Here’s How Intrexon Might Prove Me Wrong
Motley Fool Synthetic biology toolkit: One of the most difficult things about developing the technology platform is figuring out how to work with gas fermentation at the lab scale. Intrexon spent a lot of time developing completely new equipment to accomplish this … Intrexon Corp (NYSE:XON) Institutional Investors SentimentBZ Weekly Intrexon Corporation – Receive News & Ratings DailyRincon Hill News |
|
ViroMed Gene Therapy for Non-Healing Diabetic Foot Ulcers Starts Phase III Trial
Genetic Engineering & Biotechnology News The first patient has been dosed in a Phase III trial assessing ViroMed’s VM202, the first pivotal study of a gene therapy indicated for patients with non-healing diabetic foot ulcers (NHU) and concomitant peripheral artery disease (PAD). The Phase 3 … |
Genetic Literacy Project |
What is CRISPR-Cas9, how does gene editing work, who discovered the technique and could it mean we live longer?
The Sun BREAKTHROUGHS in gene editing have paved the way for scientists to fix “faulty” DNA in humans, potentially wiping out inherited diseases for good. Here is all you need to know about the revolutionary CRISPR-Cas9 technique, what it means for future … Understanding how CRISPR works: The basicsGenetic Literacy Project Human Embryos Edited For The First Time In The US-Using CRISPRiGyaan Network (blog) |
Bloomberg |
China Regenerative’s Stem Cell Research Sparks Hope
Bloomberg Stem cells can become just about any sort of tissue, if cultivated correctly. With so many potential applications, the companies that perfect the use of stem cells first will stake a claim on massive profits. Hong Kong’s China Regenerative Medicine is … |